Skip to content

Adaptive Systems Biology Supplement Study

Adaptive Systems Biology Supplement Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000283
Enrollment
90
Registered
2011-12-01
Start date
2011-07-26
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consumption of DOUBLE X, 2 times/day, 6 tablets/times(two each of three different tablets)

Sponsors

Ewha Womans University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) An equal number of men and women aged 25 to 69 years, with no more than thirty percent of all subjects younger than 40 years of age. 2) Recommended Foods Score of 36 or less. 3) No active disease (controlled hypertension is acceptable). 4) Taking no supplements or vitamins during or for 2 weeks before study. 5) Subjects with other well-controlled medical conditions that the Principal Investigator(Dr.Ko) judges to be of benign nature (e.g. well-controlled asthma) will also be allowed into the study. 6) Smokers and non-smokers will both be allowed into the study.

Exclusion criteria

Exclusion criteria: 1) Use of multivitamin/mineral supplements within two weeks of the Screening visit. 2) Currently treated for uncontrolled hypertension or blood pressure greater > 160 mm Hg systolic or > 100 mm Hg diastolic during seated. 3) Therapeutic uses of coumadin, aspirin, or other medications that influence hemostasis within four weeks of the Screening visit. Preventive use of low-dose aspirin (e.g. 100-mg a day) is allowed. 4) Participation in another clinical trial within 30 days of enrollment into the study. 5) History or current abuse of drugs or alcohol, or intake > 64 g pure alcohol/day. 6) Known hypersensitivity to study product or any ingredient in study product.

Design outcomes

Primary

MeasureTime frame
comet assay with and without hydrogen peroxide challenge

Secondary

MeasureTime frame
plasma transcobalamin, folate, carotene, homocysteine, total glutathione peroxidase, oxidized LDL, plasma malondialdehyde, total antioxidant status, lymphocyte 8-OHdG

Countries

Korea, Republic of

Contacts

Public ContactJiyeon Kim

Ewha Womans University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026